[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IL102815A0 - Pharmaceutical compositions and method for the treatment of infection caused by the human immunodeficiency virus - Google Patents

Pharmaceutical compositions and method for the treatment of infection caused by the human immunodeficiency virus

Info

Publication number
IL102815A0
IL102815A0 IL102815A IL10281592A IL102815A0 IL 102815 A0 IL102815 A0 IL 102815A0 IL 102815 A IL102815 A IL 102815A IL 10281592 A IL10281592 A IL 10281592A IL 102815 A0 IL102815 A0 IL 102815A0
Authority
IL
Israel
Prior art keywords
treatment
pharmaceutical compositions
immunodeficiency virus
human immunodeficiency
infection caused
Prior art date
Application number
IL102815A
Other versions
IL102815A (en
Original Assignee
Liposome Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Technology Inc filed Critical Liposome Technology Inc
Publication of IL102815A0 publication Critical patent/IL102815A0/en
Publication of IL102815A publication Critical patent/IL102815A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
IL102815A 1991-08-14 1992-08-14 Pharmaceutical compositions for the treatment of infection caused by the human immunodeficiency virus IL102815A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74491591A 1991-08-14 1991-08-14

Publications (2)

Publication Number Publication Date
IL102815A0 true IL102815A0 (en) 1993-01-31
IL102815A IL102815A (en) 1997-09-30

Family

ID=24994455

Family Applications (1)

Application Number Title Priority Date Filing Date
IL102815A IL102815A (en) 1991-08-14 1992-08-14 Pharmaceutical compositions for the treatment of infection caused by the human immunodeficiency virus

Country Status (5)

Country Link
EP (1) EP0599977A1 (en)
AU (1) AU664857B2 (en)
CA (1) CA2113272A1 (en)
IL (1) IL102815A (en)
WO (1) WO1993003737A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2683723B1 (en) * 1991-11-14 1995-05-19 Mayoly Spindler Laboratoires NEW ANTIVIRAL DRUGS ACTIVE ON THE HIV VIRUS.
GB2290708A (en) * 1994-06-28 1996-01-10 Georgi Stankov Pharmaceutical uses of polyene macrolides
GB2290707A (en) * 1994-06-28 1996-01-10 Georgi Stankov Pharmaceutical uses of Amphotericin B
MXPA03005655A (en) 2000-12-21 2004-12-03 Nektar Therapeutics Pulmonary delivery of polyene antifungal agents.
EP4322963A1 (en) * 2021-04-16 2024-02-21 Pannonpharma Gyógyszergyártó Kft. Treatment for viral infection with polyene macrolide antibiotic

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4822777A (en) * 1987-02-27 1989-04-18 Liposome Technology, Inc. Amphotericin B/cholesterol sulfate composition
NZ223660A (en) * 1987-03-05 1990-11-27 Liposome Co Inc Low toxicity drug-lipid complexes; methods of making them; and method of determining their toxicity
US5032404A (en) * 1989-02-23 1991-07-16 Board Of Regents, The University Of Texas System Lipsome-incorporation of polyenes

Also Published As

Publication number Publication date
EP0599977A1 (en) 1994-06-08
CA2113272A1 (en) 1993-03-04
IL102815A (en) 1997-09-30
AU664857B2 (en) 1995-12-07
WO1993003737A1 (en) 1993-03-04
AU2473092A (en) 1993-03-16

Similar Documents

Publication Publication Date Title
GB8821049D0 (en) Method & composition for treatment & prevention of viral infections
ITMI931522A0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION (HBV)
IL102092A0 (en) Vaccine and treatment method for human immunodeficiency virus
GB8900678D0 (en) Compositions for the prevention and medical treatment of parodonthopathy
EP0584558A3 (en) A composition for suppressing infection and growth of human immunodeficiency virus using an iron-binding protein.
AU1463992A (en) Methods and pharmaceutical compositions for inhibiting protease from human immunodeficiency virus
AP9300513A0 (en) Compositions for the treatment of infection and disease caused by hepatitis b virus(hbv)
AP9300581A0 (en) Benzofuran derivatives processes for their preparation and pharmaceutical compositions containing them and their medical use
IL102815A0 (en) Pharmaceutical compositions and method for the treatment of infection caused by the human immunodeficiency virus
IL111338A0 (en) Pharmaceutical or veterinary compositions comprising flavin derivatives for the treatment of viral infections and their preparation
ZA9510108B (en) Composition and method for prevention and treatment of HIV-1 infection
AU591017B2 (en) Human monoclonal antibody and drug for prophylaxis and treatment of infectious diseases comprising same as effective ingredient
EP0491873A4 (en) Therapeutic compositions; methods for treatment of hiv infections
GB2255718B (en) Pharmaceutical composition for treating bacterial and / or viral infection
IL96667A0 (en) Pharmaceutical compositions containing fibroblast growth factors for the prevention and treatment of viral infections
IL100243A0 (en) Pharmaceutical compositions for the treatment of erythrocytic malaria infections
LTIP472A (en) Composition for the treatment of infection and disease caused by hepatit b virus
PH27412A (en) Method of treatment of human immunodeficiency virus
ZA907348B (en) Method of administering soluble t4 for treatment of human immunodeficiency virus infection
ZA896503B (en) Pharmaceutical combination preparations and their use for the prophylaxis or treatment of bacterial infectious diseases
AP9000180A0 (en) Pharmaceutical composition for the treatment of protozoal diseases
AU3593095A (en) Method of treatment of human immunodeficiency virus (hiv) infection
AU4660889A (en) Method of treatment of human immunodeficiency virus
IT9021051A0 (en) "PROCEDURE FOR EXTRACTION AND PURIFICATION OF RECOMBITE HUMAN INTERFERON GAMMA"
AU2880495A (en) Use of pharmaceutical agents for alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees